Stockreport

Analysts Have Lowered Expectations For Vir Biotechnology, Inc. (NASDAQ:VIR) After Its Latest Results [Yahoo! Finance]

Vir Biotechnology, Inc.  (VIR) 
PDF It looks like a positive result overall, with revenues of US$74m beating forecasts by 8.1%. Statutory losses of US$3.83 per share were 8.1% smaller than the analysts exp [Read more]